Phoebe Putney Memorial Hospital INC

Phoebe Putney Memorial Hospital INC was paid $84.34M by Medicaid between Jan 2018 and Dec 2024, across 607 billing codes. Its largest line is 99284, emergency room visit (serious) — 10% of everything it billed.

33Billing provider infoPHOEBE PUTNEY MEMORIAL HOSPITAL INC
ALBANY, GA 31701

33aNPI1992789721assigned 12/05/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$84.34M

24GClaims2,293,849

24DCodes billed607

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Georgia

Rank by total paid#2 of 34

Median peer was paid$23K

This provider vs. median3,655×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	402,166	$11.61M
2019	398,689	$12.08M
2020	301,257	$9.29M
2021	307,378	$11.33M
2022	312,142	$14.31M
2023	330,842	$14.96M
2024incomplete	241,375	$10.74M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	10%	82,378	76,286	$8.46M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.1%	72,366	65,961	$6.85M
74177	Computed tomography, abdomen and pelvis; with contrast material	4.8%	8,772	8,019	$4.04M
J9271	Injection, pembrolizumab, 1 mg	3.6%	1,022	686	$3.04M
0202U	Oncology (prostate), multianalyte, gene expression profiling	2.6%	7,006	6,786	$2.15M
70450	Computed tomography, head or brain; without contrast material	2.5%	10,948	9,867	$2.13M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.1%	10,670	9,664	$1.81M
G0378	Hospital observation service, per hour	2.1%	16,193	7,203	$1.74M
96361	Intravenous infusion, hydration; each additional hour	1.9%	18,959	14,437	$1.62M
96375	Therapeutic injection; each additional sequential IV push	1.7%	28,287	20,297	$1.41M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.6%	16,488	12,212	$1.36M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.6%	19,735	18,075	$1.32M

595 more codes

99213	Doctor's office visit, returning patient (routine)	1.5%	49,340	$1.25M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.5%	4,047	$1.25M
42820	Tonsillectomy and adenoidectomy; younger than age 12	1.5%	1,027	$1.25M
36902		1.4%	3,200	$1.22M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.4%	5,330	$1.21M
99214	Doctor's office visit, returning patient (more involved)	1.4%	28,642	$1.15M
J0897	Injection, denosumab, 1 mg	1.3%	1,744	$1.09M
71260	Computed tomography, thorax, diagnostic; with contrast material	1.2%	5,448	$1.04M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.2%	28,663	$1.02M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	1.1%	2,440	$968K
78815	Positron emission tomography (PET) for limited area imaging	1.1%	1,559	$945K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.1%	33,274	$897K
80053	Comprehensive metabolic panel	<1%	110,361	$819K
71045	Radiologic examination, chest; single view	<1%	23,963	$796K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	1,916	$788K
71046	Radiologic examination, chest; 2 views	<1%	19,622	$779K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	38,168	$770K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	10,508	$766K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	4,133	$744K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	126,062	$715K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,166	$704K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	5,984	$665K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,040	$644K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	924	$643K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	11,806	$609K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	1,604	$565K
S9123	Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used)	<1%	10,446	$556K
96367		<1%	7,699	$529K
77412		<1%	6,369	$529K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	25,822	$485K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	19,925	$468K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	10,011	$446K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,898	$431K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,452	$399K
96376		<1%	8,490	$390K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,489	$389K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	6,590	$382K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	4,218	$378K
D7140	Extraction, erupted tooth or exposed root	<1%	1,358	$378K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,394	$369K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	11,203	$362K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,617	$362K
36430		<1%	3,110	$346K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	16,806	$345K
77336		<1%	4,291	$333K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	3,903	$320K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	7,093	$316K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,247	$279K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	3,969	$275K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	8,615	$268K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	10,463	$252K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,614	$239K
76801		<1%	1,720	$238K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	840	$235K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	22,213	$227K
77334		<1%	1,321	$225K
84443	Thyroid stimulating hormone (TSH)	<1%	16,755	$223K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,550	$211K
84484		<1%	22,674	$209K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,243	$208K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	7,710	$207K
71250		<1%	2,977	$197K
J2505	Injection, pegfilgrastim, 6 mg	<1%	185	$192K
95811		<1%	350	$192K
96417		<1%	3,364	$189K
93971		<1%	2,317	$188K
96368		<1%	3,189	$187K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,922	$185K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,824	$177K
74018		<1%	4,454	$175K
93017		<1%	2,863	$169K
80048	Basic metabolic panel (calcium, ionized)	<1%	28,733	$154K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,258	$151K
83880		<1%	6,306	$148K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	8,594	$148K
73221		<1%	865	$147K
36907		<1%	622	$143K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	462	$137K
77300		<1%	1,261	$137K
73562		<1%	2,343	$132K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	11,707	$128K
G0151	Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes	<1%	3,056	$123K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	456	$123K
81025		<1%	19,089	$119K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	5,344	$116K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,445	$116K
87430		<1%	10,904	$116K
83735		<1%	26,599	$115K
73030		<1%	2,184	$109K
86901		<1%	11,445	$108K
74022		<1%	1,681	$107K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,158	$106K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	57	$105K
96415		<1%	2,120	$104K
87070		<1%	13,185	$104K
36905		<1%	417	$103K
73630		<1%	1,760	$101K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,802	$100K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	5,347	$98K
D2934		<1%	422	$98K
Q5001	Hospice or home health care provided in patient's home/residence	<1%	93	$97K
D3220	Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction	<1%	567	$97K
D2330		<1%	369	$97K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,565	$96K
82553		<1%	11,248	$95K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,353	$94K
81001		<1%	37,401	$93K
76641		<1%	1,725	$93K
82948		<1%	28,062	$91K
86850		<1%	9,219	$88K
77295		<1%	149	$88K
77063	Screening digital breast tomosynthesis, bilateral	<1%	6,500	$86K
77290		<1%	268	$86K
76770		<1%	1,953	$85K
73610		<1%	1,369	$84K
85027		<1%	20,643	$83K
93970		<1%	775	$82K
83690		<1%	14,350	$81K
D2140		<1%	152	$80K
36591		<1%	14,315	$80K
72100		<1%	1,618	$78K
76830	Ultrasound, transvaginal	<1%	1,036	$78K
73502		<1%	1,690	$76K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	19,205	$76K
87086	Culture, bacterial; quantitative colony count, urine	<1%	10,540	$76K
80061	Lipid panel	<1%	10,559	$75K
J1453	Injection, fosaprepitant, 1 mg	<1%	971	$73K
80320		<1%	4,281	$73K
80329		<1%	1,577	$72K
87040		<1%	5,765	$72K
88312		<1%	2,896	$71K
82728		<1%	7,821	$70K
73130		<1%	1,268	$69K
97162		<1%	3,419	$68K
72141		<1%	430	$68K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	432	$67K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	937	$67K
J9035	Injection, bevacizumab, 10 mg	<1%	69	$66K
D2335		<1%	166	$65K
70486		<1%	333	$65K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	813	$64K
APT15		<1%	5,631	$63K
88307		<1%	563	$63K
82607		<1%	5,189	$60K
83605		<1%	7,143	$60K
82803		<1%	3,846	$58K
88342		<1%	1,982	$57K
99232	Hospital visit by a doctor, follow-up day	<1%	1,371	$56K
88341		<1%	774	$56K
85610		<1%	21,330	$56K
84466		<1%	6,526	$55K
77427		<1%	682	$52K
97163		<1%	3,306	$51K
93880		<1%	627	$51K
83036	Hemoglobin; glycosylated (A1C)	<1%	5,887	$50K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	33,452	$50K
76536		<1%	1,009	$48K
J2997	Injection, alteplase recombinant, 1 mg	<1%	856	$48K
84439		<1%	6,183	$48K
85730		<1%	11,724	$46K
72131		<1%	205	$45K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	2,257	$45K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	241	$44K
82550		<1%	14,987	$44K
86900		<1%	12,626	$43K
93976		<1%	251	$42K
73560		<1%	1,002	$41K
84702		<1%	5,559	$41K
73590		<1%	744	$41K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,459	$41K
87400		<1%	4,369	$40K
93356		<1%	1,164	$40K
D2150	Silver amalgam - two surfaces, primary or permanent	<1%	135	$40K
88304		<1%	1,563	$37K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	86	$35K
82784		<1%	2,812	$35K
92523		<1%	516	$35K
70491		<1%	188	$34K
77065	Tomosynthesis, mammo	<1%	997	$34K
76000		<1%	688	$34K
76937		<1%	1,613	$33K
86140		<1%	6,999	$33K
J1815	Injection, insulin, per 5 units	<1%	5,372	$32K
83520		<1%	1,803	$32K
73110		<1%	623	$32K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,850	$32K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,073	$31K
97597		<1%	838	$31K
87428		<1%	898	$31K
83540		<1%	6,882	$30K
G6002	Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	<1%	2,953	$30K
90791	Psychiatric diagnostic evaluation	<1%	1,208	$30K
APT17		<1%	2,041	$30K
97116		<1%	5,272	$30K
86923		<1%	2,310	$30K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	5,016	$30K
J1756	Injection, iron sucrose, 1 mg	<1%	1,361	$29K
87077		<1%	4,093	$29K
77066	Tomosynthesis, mammo	<1%	572	$29K
76942		<1%	509	$29K
87186		<1%	3,947	$29K
95813		<1%	84	$29K
95816		<1%	248	$29K
82565		<1%	8,588	$29K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,939	$29K
96411		<1%	1,344	$28K
76775		<1%	543	$28K
77014		<1%	1,244	$28K
85379		<1%	3,796	$28K
43249		<1%	311	$28K
84703		<1%	3,935	$27K
72040		<1%	310	$27K
99204	Doctor's office visit, new patient (more involved)	<1%	608	$26K
93458		<1%	27	$26K
81003		<1%	14,962	$26K
99201		<1%	1,221	$25K
77280		<1%	152	$25K
75710		<1%	81	$24K
77001		<1%	403	$24K
84153		<1%	2,137	$24K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	40,234	$24K
73090		<1%	401	$24K
72110		<1%	369	$24K
82570		<1%	4,931	$23K
72170		<1%	521	$23K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	326	$23K
87807		<1%	2,236	$23K
87899		<1%	1,830	$22K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	23,836	$21K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	18,120	$21K
36415	Collection of venous blood by venipuncture	<1%	106,878	$21K
J1170	Injection, hydromorphone, up to 4 mg	<1%	14,098	$21K
80074		<1%	463	$20K
82746		<1%	1,863	$19K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	2,536	$19K
80076		<1%	4,238	$19K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	488	$19K
G0390	Trauma response team associated with hospital critical care service	<1%	14	$18K
86703		<1%	1,355	$18K
86038		<1%	1,646	$18K
74019		<1%	365	$18K
76819	Fetal biophysical profile; without non-stress testing	<1%	127	$18K
97032		<1%	2,925	$17K
95886		<1%	145	$17K
96402		<1%	525	$17K
76642		<1%	465	$17K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	19,246	$17K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	99	$17K
G0379	Direct admission of patient for hospital observation care	<1%	717	$17K
88112		<1%	723	$17K
90715		<1%	784	$16K
83970		<1%	465	$16K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	4,576	$16K
84481		<1%	1,296	$16K
85045		<1%	4,515	$15K
76870		<1%	127	$15K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,888	$15K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	8,543	$15K
83615		<1%	4,798	$15K
86334		<1%	1,489	$15K
77301		<1%	24	$15K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	8,319	$14K
74220		<1%	295	$14K
88142		<1%	692	$14K
APT16		<1%	1,002	$14K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,430	$13K
85652		<1%	5,527	$13K
96401		<1%	644	$13K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	2,342	$13K
84550		<1%	3,865	$13K
92611		<1%	127	$12K
J2060	Injection, lorazepam, 2 mg	<1%	2,564	$12K
12001		<1%	136	$12K
82378		<1%	1,296	$12K
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	<1%	1,264	$11K
83718		<1%	998	$11K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,416	$11K
36600		<1%	1,564	$11K
95911		<1%	26	$11K
74178		<1%	53	$11K
84156		<1%	3,003	$11K
J0690	Injection, cefazolin sodium, 500 mg	<1%	6,324	$11K
97014		<1%	1,050	$10K
87210		<1%	2,479	$10K
J9190	Injection, fluorouracil, 500 mg	<1%	1,497	$10K
74230		<1%	128	$9K
Q3014	Telehealth originating site facility fee	<1%	446	$9K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	3,844	$9K
80361		<1%	356	$9K
85520		<1%	988	$9K
83883		<1%	849	$9K
82043		<1%	1,965	$9K
97166		<1%	817	$9K
97535	Self-care/home management training, each 15 minutes	<1%	2,236	$9K
80363		<1%	356	$9K
97035		<1%	1,149	$9K
83655		<1%	785	$8K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	299	$8K
80346		<1%	358	$8K
73552		<1%	167	$8K
92588		<1%	112	$8K
84450		<1%	2,345	$8K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,838	$8K
90792	Psychiatric diagnostic evaluation with medical services	<1%	67	$8K
36589		<1%	82	$7K
84145		<1%	947	$7K
80358		<1%	357	$7K
36561		<1%	20	$7K
99215	Doctor's office visit, returning patient (complex)	<1%	96	$7K
29125		<1%	67	$7K
77080		<1%	350	$7K
96416		<1%	78	$7K
92585		<1%	34	$7K
83992		<1%	366	$7K
C1889	Implantable/insertable device, not otherwise classified	<1%	359	$7K
87205		<1%	3,368	$7K
90837	Psychotherapy session, about an hour	<1%	59	$6K
86803		<1%	992	$6K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,365	$6K
84166		<1%	786	$6K
86235		<1%	83	$6K
94644		<1%	548	$6K
80369		<1%	245	$5K
51702		<1%	184	$5K
12011		<1%	57	$5K
92587		<1%	116	$5K
82248		<1%	1,212	$5K
86480		<1%	80	$5K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	21,323	$5K
87147		<1%	1,197	$5K
84100		<1%	4,139	$5K
36593		<1%	43	$5K
82274		<1%	373	$5K
J9045	Injection, carboplatin, 50 mg	<1%	439	$5K
80324		<1%	236	$5K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	2,858	$5K
82140		<1%	743	$5K
97161		<1%	395	$5K
J1953	Injection, levetiracetam, 10 mg	<1%	557	$5K
80353		<1%	357	$4K
86160		<1%	262	$4K
87806		<1%	214	$4K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	30	$4K
87340		<1%	459	$4K
90686		<1%	341	$4K
71271		<1%	96	$4K
12002		<1%	29	$4K
D2332		<1%	29	$4K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	48	$4K
36558		<1%	17	$4K
J9171	Injection, docetaxel, 1 mg	<1%	55	$4K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	47	$4K
J7510	Prednisolone oral, per 5 mg	<1%	566	$3K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	654	$3K
95909		<1%	12	$3K
92650		<1%	26	$3K
86592		<1%	952	$3K
83516		<1%	268	$3K
84112		<1%	59	$3K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	82	$3K
82785		<1%	178	$3K
82247		<1%	745	$3K
51701		<1%	78	$3K
J1644	Injection, heparin sodium, per 1000 units	<1%	10,014	$3K
84520		<1%	1,743	$3K
86902		<1%	318	$3K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	575	$3K
87522	Neg quan hep c or qual rna	<1%	97	$3K
87075		<1%	402	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	17,217	$3K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	1,750	$3K
85018		<1%	1,648	$3K
62323		<1%	99	$3K
84165		<1%	564	$3K
99203	Doctor's office visit, new patient (routine)	<1%	69	$3K
80336		<1%	120	$3K
J3480	Injection, potassium chloride, per 2 meq	<1%	3,715	$3K
80370		<1%	120	$3K
80164		<1%	251	$3K
92567		<1%	143	$3K
82747		<1%	241	$3K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	420	$3K
74160		<1%	35	$3K
93225		<1%	30	$2K
93226		<1%	32	$2K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	932	$2K
85014		<1%	1,994	$2K
82009		<1%	893	$2K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	3,749	$2K
82731		<1%	32	$2K
88720		<1%	593	$2K
43235		<1%	15	$2K
31500		<1%	24	$2K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,477	$2K
80325		<1%	117	$2K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	446	$2K
77003		<1%	15	$2K
86300		<1%	150	$2K
97802		<1%	59	$2K
80342		<1%	120	$2K
77338		<1%	29	$2K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	314	$2K
64415		<1%	223	$2K
70496		<1%	13	$2K
87102		<1%	276	$2K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	1,368	$2K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	460	$2K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	12	$2K
77417		<1%	54	$2K
85660		<1%	315	$2K
90834	Psychotherapy session, about 45 minutes	<1%	21	$2K
J3360	Injection, diazepam, up to 5 mg	<1%	425	$2K
86317		<1%	15	$1K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	76	$1K
73060		<1%	26	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	94	$1K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,884	$1K
77387		<1%	844	$1K
36416		<1%	3,150	$1K
71101		<1%	13	$1K
82465		<1%	400	$1K
82330		<1%	167	$1K
94002		<1%	19	$1K
92950		<1%	21	$1K
94729		<1%	40	$1K
0399T		<1%	158	$1K
29581		<1%	63	$1K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	281	$1K
J9267	Injection, paclitaxel, 1 mg	<1%	87	$1K
36215		<1%	15	$1K
87420		<1%	165	$1K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	199	$1K
94726		<1%	27	$1K
86376		<1%	69	$1K
85384		<1%	143	$1K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	231	$1K
36901		<1%	14	$1K
84460		<1%	844	$1K
84132		<1%	800	$1K
86225		<1%	78	$998.48
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	12	$981.55
86200		<1%	80	$980.62
80356		<1%	351	$969.88
82040		<1%	713	$955.22
J1171	Injection, hydromorphone, 0.1 mg	<1%	348	$920.57
82533		<1%	72	$913.77
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	47	$908.97
94060		<1%	12	$870.16
73100		<1%	16	$867.84
87081		<1%	175	$864.28
A9576	Injection, gadoteridol, (prohance multipack), per ml	<1%	30	$859.66
87206		<1%	189	$851.23
82951		<1%	52	$849.19
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,465	$843.92
J1940	Injection, furosemide, up to 20 mg	<1%	2,256	$843.80
80069		<1%	273	$840.25
C1819	Surgical tissue localization and excision device (implantable)	<1%	212	$835.62
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	445	$832.73
17250		<1%	90	$818.91
84155		<1%	1,007	$810.19
86762		<1%	43	$803.55
83021		<1%	138	$796.06
77263		<1%	14	$780.67
43450		<1%	15	$755.68
APT18		<1%	53	$730.00
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	33	$714.45
73070		<1%	14	$694.58
87015		<1%	182	$687.85
APT14		<1%	60	$686.34
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	24	$667.06
97033		<1%	64	$648.33
29515		<1%	14	$642.11
86920		<1%	86	$633.23
92526		<1%	94	$619.84
80354		<1%	352	$579.30
80373		<1%	347	$559.33
80348		<1%	350	$535.34
82164		<1%	41	$518.97
J0595	Injection, butorphanol tartrate, 1 mg	<1%	108	$514.82
80365		<1%	350	$514.43
86704		<1%	39	$511.83
80368		<1%	112	$503.16
86706		<1%	60	$502.23
80349		<1%	350	$496.53
97016		<1%	53	$488.54
APT02		<1%	71	$468.61
43760		<1%	12	$466.36
97167		<1%	32	$466.27
80355		<1%	347	$457.22
80366		<1%	346	$454.90
80359		<1%	353	$445.73
87046		<1%	62	$440.02
80372		<1%	346	$429.71
80367		<1%	347	$429.71
86696		<1%	13	$398.00
87045		<1%	50	$395.54
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	28	$391.90
82232		<1%	30	$390.59
86255		<1%	29	$379.31
80202		<1%	57	$377.43
76998		<1%	18	$360.28
81002		<1%	170	$357.05
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	129	$354.42
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	55	$349.48
J1630	Injection, haloperidol, up to 5 mg	<1%	522	$343.06
93922		<1%	13	$339.74
APT09		<1%	43	$321.57
96523		<1%	91	$317.09
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	98	$315.83
84403		<1%	13	$315.16
0011A		<1%	43	$287.30
94200		<1%	25	$283.15
82977		<1%	117	$272.65
86695		<1%	13	$268.13
86708		<1%	25	$263.93
87209		<1%	13	$262.21
82310		<1%	62	$249.75
0012A		<1%	14	$248.01
J1790	Injection, droperidol, up to 5 mg	<1%	113	$243.14
51798		<1%	25	$237.10
80360		<1%	114	$234.92
80357		<1%	113	$234.92
80333		<1%	112	$234.92
86705		<1%	29	$231.59
87653		<1%	13	$222.18
86922		<1%	38	$208.46
82952		<1%	51	$171.74
82947		<1%	87	$162.66
76001		<1%	83	$154.01
86039		<1%	19	$151.15
80185		<1%	12	$142.75
87177		<1%	13	$129.82
86921		<1%	38	$128.34
87449		<1%	13	$127.12
82955		<1%	12	$115.21
82105		<1%	14	$111.05
86880		<1%	25	$110.72
84436		<1%	31	$109.81
86870		<1%	25	$104.94
J0461	Injection, atropine sulfate, 0.01 mg	<1%	21	$103.06
85651		<1%	23	$102.21
87324		<1%	14	$96.81
82150		<1%	13	$94.96
80177		<1%	13	$77.19
84295		<1%	94	$75.31
86304		<1%	15	$69.39
83010		<1%	33	$67.71
J3411	Injection, thiamine hcl, 100 mg	<1%	30	$63.94
J1956	Injection, levofloxacin, 250 mg	<1%	34	$62.82
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	21	$62.62
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	61	$59.46
83986		<1%	19	$53.80
82272		<1%	13	$43.46
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	12	$41.15
89055		<1%	16	$36.16
82542		<1%	12	$34.89
J7030	Infusion, normal saline solution , 1000 cc	<1%	74	$30.21
96377		<1%	19	$29.50
99406		<1%	22	$26.52
J7120	Ringers lactate infusion, up to 1000 cc	<1%	32	$18.19
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	3,273	$17.52
J0456	Injection, azithromycin, 500 mg	<1%	15	$14.55
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	234	$5.89
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	53	$5.42
A4649	Surgical supply; miscellaneous	<1%	928	$2.24
A9270	Non-covered item or service	<1%	12,832	$1.76
A9150	Non-prescription drugs	<1%	12	$0.30
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	46	$0.11
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	818	$0.02
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	855	$0.02
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	73	$0.01
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	207	$0.01
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	204	$0.01
C1757	Catheter, thrombectomy/embolectomy	0%	1,395	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	950	$0.00
80338		0%	112	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	13	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	15	$0.00
C1874	Stent, coated/covered, with delivery system	0%	48	$0.00
90662		0%	17	$0.00
99053		0%	73	$0.00
99442		0%	17	$0.00
G0008	Administration of influenza virus vaccine	0%	121	$0.00
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	0%	401	$0.00
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	0%	56	$0.00
G8950	Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented	0%	89	$0.00
C1769	Guide wire	0%	3,600	$0.00
A4215	Needle, sterile, any size, each	0%	797	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	3,784	$0.00
90935	Hemodialysis procedure with single evaluation by a physician	0%	31	$0.00
V2632	Posterior chamber intraocular lens	0%	48	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	51	$0.00
90654		0%	21	$0.00
74174		0%	15	$0.00
A6213	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCHURCH, BRIAN (CFO)